ReviewLung2013
Management of malignant pleural effusion.
Review in Lung, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 6 syntheses or guidelines pooled it, 79 citations in OpenAlex.
- Thoracic perfusion of recombinant mutant human tumor necrosis factor (rmhTNF) can be considered as a good adjunct in the treatment of malignant pleural effusion caused by lung cancer.BMC pulmonary medicine · 2020Pooled it
- Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis.BMC cancer · 2017Pooled it
- Diagnostic accuracy of calretinin for malignant mesothelioma in serous effusions: a meta-analysis.Scientific reports · 2015Pooled it
- Diagnostic accuracy of MOC-31 for malignant effusions: a meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014Pooled it
- Diagnostic accuracy of Ber-EP4 for metastatic adenocarcinoma in serous effusions: a meta-analysis.PloS one · 2014Pooled it
- Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis.PloS one · 2014Pooled it
- A Study Investigating Markers in PLeural Effusion (SIMPLE): a prospective and double-blind diagnostic study.BMJ open · 2019Trial
- A Randomized Controlled Study to Observe the Efficacy of External Treatment With a Traditional Chinese Medicine Herbal Ointment on Malignant Plural Effusion: Outcome Report and Design Review.Integrative cancer therapies · 2017Trial
- Chemical Pleurodesis Using Mistletoe Extraction (ABNOVAviscum(®) Injection) for Malignant Pleural Effusion.Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia · 2016Trial
- Bringing AI to Clinicians: Simplifying Pleural Effusion Cytology Diagnosis with User-Friendly Models.Diagnostics (Basel, Switzerland) · 2025Article
- Lung cancer cells detection by a photoelectrochemical MoSBiomedical optics express · 2024Article
- A Microfluidic System for Detecting Tumor Cells Based on Biomarker Hexaminolevulinate (HAL): Applications in Pleural Effusion.Micromachines · 2023Article
- Malignant effusions secondary to metastatic thyroid carcinomas: A review of 15 cases.Cancer cytopathology · 2023Review
- Effectiveness and Safety of Real-Time Transthoracic Ultrasound-Guided Thoracentesis.Diagnostics (Basel, Switzerland) · 2022Article
- Article
- Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study.BMC cancer · 2020Article
- The Focused Assessment with Sonography in Cancer (FASC) Examination.POCUS journal · 2020Article
- Sarcopenia in patients with malignant pleural effusion: impact on symptoms, health status, and response to hospitalization.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019Observational
- Diagnostic value of CD206Journal of thoracic disease · 2019Article
- Pleural fluid due to papillary thyroid cancer.Oncology letters · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malignancy is one of the most common causes of pleural effusion. Malignant pleural effusion is defined by the presence of malignant cells in the pleural fluid. Development of malignant pleural effusion usually defines advanced malignancy. Pathophysiology of malignant pleural effusion is not fully understood and may involve complex interactions between the mesothelial and malignant cells. Investigations and management of patients with malignant pleural effusion require a multidisciplinary approach. In this review, current practice for management of patients with malignant pleural effusion will be discussed. In addition, imaging techniques will be covered, including the use of thoracic ultrasound and its role in image-guiding pleural procedures. Moreover, interventional techniques will be described, such as medical thoracoscopy, the use of indwelling pleural catheters, or surgery for investigation and management of malignant pleural effusion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.